DK419 |
Katalog-Nr.GC35873 |
DK419 ist ein potenter und oral aktiver Wnt/β-Catenin-Signalweg-Inhibitor mit einem IC50-Wert von 0,19 μM. DK419 reduziert die Proteinspiegel von Axin2, β-Catenin, c-Myc, Cyclin D1 und Survivin und induziert die Produktion von pAMPK.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2102672-22-8
Sample solution is provided at 25 µL, 10mM.
DK419 is a potent and orally active Wnt/β-catenin signaling inhibitor, with an IC50 of 0.19 μM. DK419 reduces protein lelvels of Axin2, β-catenin, c-Myc, Cyclin D1 and Survivin and induces production of pAMPK[1]. Wnt/β-catenin[1]
[1]. Wang J, et al. Identification of DK419, a potent inhibitor of Wnt/β-catenin signaling and colorectal cancer growth. Bioorg Med Chem. 2018 Nov 1;26(20):5435-5442.
Average Rating: 5
(Based on Reviews and 6 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *